Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.

Abstract:

OBJECTIVE:The aim of this study was to define the pharmacokinetic profile of free carbamazepine (F-CBZ) in adult Omani epileptic patients in order to improve on dosing schedules through population pharmacokinetic analysis using the NONMEM program. METHOD:Steady-state trough F-CBZ serum concentrations, carbamazepine (CBZ) dosing history and associated information were collected prospectively. RESULTS:Forty-eight patients with two or more available F-CBZ serum concentrations (total of 149 dose/serum concentration pairs) met our inclusion criteria. Patients were taking CBZ (200-1200 mg/day) in monotherapy. The analysis assumed a one-compartmental open model with first-order absorption and elimination. The apparent clearance (CL/F) and apparent volume of distribution (V/F) and their interindividual variabilities were estimated using the program. The population estimates for clearance (CL; modelled independently of dose) and volume of distribution were 13.2 +/- 0.6 l/h and 525 +/- 44 1, respectively. However, CL increased as a function of dosing rate and consequently was modelled as a linear function of steady-state concentration. In order to validate these results, the predictions of the population model were tested against data from 13 further patients subjected to the same inclusion criteria but who were not included in the original analysis. The predictions were good, being unbiased (P=0.31), and had an average deviation from the observed values of 18%. CONCLUSION:In order to establish steady-state dosage regimens, a population pharmacokinetic model is proposed, based on the patient's dose, to estimate the individual CL for an Omani epileptic patient receiving CBZ in monotherapy.

journal_name

Eur J Clin Pharmacol

authors

Deleu D,Aarons L,Ahmed IA

doi

10.1007/s002280100300

subject

Has Abstract

pub_date

2001-06-01 00:00:00

pages

243-8

issue

3

eissn

0031-6970

issn

1432-1041

journal_volume

57

pub_type

临床试验,杂志文章
  • Dose response relationship of clenbuterol (NAB 365) as a solution for inhalation.

    abstract::The dose-response relationship of the new bronchodilator Clenbuterol (NAB 365, Boehringer Ingelheim) was tested in 12 patients with chronic obstructive lung disease. Clenbuterol is a beta-2-sympathicomimetic, from a series of substituted phenylethanolamines, and it is characterised by good absorption and prolonged act...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00563099

    authors: Tschan M,Perruchoud A,Herzog H

    更新日期:1979-04-17 00:00:00

  • Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor.

    abstract:PURPOSE:LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor, is indicated for chronic heart failure (HF) and reduced ejection fraction (HFrEF) to reduce the risk of cardiovascular death and hospitalization for HF. Following oral administration, LCZ696 provides systemic exposure to valsartan and ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-016-2072-7

    authors: Ayalasomayajula SP,Langenickel TH,Jordaan P,Zhou W,Chandra P,Albrecht D,Pal P,Rajman I,Sunkara G

    更新日期:2016-09-01 00:00:00

  • Cardiocirculatory effects of moclobemide (Ro 11-1163), a new reversible, a short-acting MAO-inhibitor with preferential type A inhibition, in healthy volunteers and depressive patients.

    abstract::The benzamide-derivative moclobemide (Ro 11-1163) is a new short-acting, reversible MAO-inhibitor, preferentially affecting Type A MAO, which is, being developed as an antidepressant agent. The effect of moclobemide on heart rate, blood pressure, electrocardiographic and systolic time intervals was assessed in eight h...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00543787

    authors: Gasic S,Korn A,Eichler HG,Oberhummer I,Zapotoczky HG

    更新日期:1983-01-01 00:00:00

  • Effects of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in man.

    abstract:OBJECTIVE:In the present randomized, fourway crossover study we determined the effects of two oral doses each of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in man. METHODS:Twelve healthy female volunteers received for 2 consecutive days, followed by a 5-day drug-free interval, one of the...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s002280050189

    authors: Stichtenoth DO,Tsikas D,Gutzki FM,Frölich JC

    更新日期:1996-01-01 00:00:00

  • Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study.

    abstract:PURPOSE:The study aimed to describe the dispensing of benzodiazepines and benzodiazepine-related drugs (z-hypnotics) to pregnant women and to study the characteristics of these women and the extent of co-medication. METHODS:A population-based cohort study was conducted based on the linkage of nationwide registries: th...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-014-1744-4

    authors: Riska BS,Skurtveit S,Furu K,Engeland A,Handal M

    更新日期:2014-11-01 00:00:00

  • Corticosteroid therapy and need for hospital care in wheezing preschool children.

    abstract:OBJECTIVES:To study the frequency of corticosteroid therapy and the use of inpatient care for preschool children with wheezing in two regions in Finland. METHODS:The Finnish Social Insurance Institution database on refundable asthma medication indicated that 1.18% of children in Tampere and 2.37% in Turku used inhaled...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280000199

    authors: Csonka P,Mertsola J,Klaukka T,Kaila M,Ståhlberg MR,Ashorn P

    更新日期:2000-11-01 00:00:00

  • Population approaches in drug development. Report on an expert meeting to discuss population pharmacokinetic/pharmacodynamic software.

    abstract::An expert meeting to discuss population pharmacokinetic/pharmacodynamic software was held in Brussels in November 1993 under the auspices of the European Co-operation in Science and Technology (COST), Medicine (B1) programme. Recently developed statistical methods offer the possibility of gaining integrated informatio...

    journal_title:European journal of clinical pharmacology

    pub_type:

    doi:10.1007/BF00191898

    authors: Aarons L,Balant LP,Mentré F,Morselli PL,Rowland M,Steimer JL,Vozeh S

    更新日期:1994-01-01 00:00:00

  • Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine.

    abstract::The peripheral histamine-inhibiting and central sedative effects of single oral doses (SOD) and of repeated administration for one week (steady state, SS), of 20 mg hydroxyzine HCL and 10 mg cetirizine have been assessed in 12 healthy volunteers, in a double-blind placebo-controlled cross-over study. Peripheral H1-rec...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00626365

    authors: Levander S,Ståhle-Bäckdahl M,Hägermark O

    更新日期:1991-01-01 00:00:00

  • Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

    abstract:BACKGROUND:Visual hallucinations (VHs) are frequent non-motor complication of Parkinson's disease (PD), associated to a negative prognosis. Previous studies showed an association between dopamine receptor (DR) gene (DR) variants and psychosis in Alzheimer's disease, addictions, schizophrenia, and bipolar disorder. Howe...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-016-2111-4

    authors: Ferrari M,Comi C,Marino F,Magistrelli L,De Marchi F,Cantello R,Riboldazzi G,Bono G,Cosentino M

    更新日期:2016-11-01 00:00:00

  • Population pharmacokinetics of PEGylated liposomal CPT-11 (IHL-305) in patients with advanced solid tumors.

    abstract:PURPOSE:To investigate pharmacokinetics (PK) of encapsulated CPT-11, released CPT-11 and the active metabolite SN-38 following administration of IHL-305 and to identify factors that may influence IHL-305 PK. METHODS:Plasma samples from 39 patients with solid tumors were collected in a phase I study. IHL-305 was admini...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-013-1580-y

    authors: Wu H,Infante JR,Keedy VL,Jones SF,Chan E,Bendell JC,Lee W,Zamboni BA,Ikeda S,Kodaira H,Rothenberg ML,Burris HA 3rd,Zamboni WC

    更新日期:2013-12-01 00:00:00

  • Utilisation of codeine and propoxyphene: geographic and demographic variations in prescribing, prescriber and recipient categories.

    abstract:OBJECTIVES:To assess (1) whether the utilisation of codeine or propoxyphene differs among the three major Swedish cities (Stockholm, Göteborg and Malmö) and between urban and semirural areas; (2) if so, whether it co-varies with the utilisation of other potentially dependence-promoting drugs, benzodiazepines; (3) what ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050680

    authors: Henricson K,Carlsten A,Ranstam J,Rametsteiner G,Stenberg P,Wessling A,Melander A

    更新日期:1999-10-01 00:00:00

  • Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels.

    abstract:PURPOSE:To investigate possible differences in the time course of vasodilating effects of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in humans. METHODS:We measured forearm blood flow (FBF) by strain gauge plethymography and cyclic GMP spillover during and after intra-arterial infusions of BNP...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-008-0516-4

    authors: Minami H,Yasu T,Tagawa T,Yamakawa K,Ueda S

    更新日期:2008-09-01 00:00:00

  • Absorption and metabolism in man of 16-epi-gitoxin, a new semi-synthetic cardioactive glycoside.

    abstract::The pharmacokinetics of 3H-16-epi-gitoxin have been investigated after oral administration: The peak serum level occurred after 30-60 min, and its subsequent decline was in two phases with half-lives of 3.5 and 19.5 h, respectively. Within 3 days 66-70% of the administered radioactivity were eliminated by renal excret...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00562938

    authors: Haustein KO

    更新日期:1977-07-19 00:00:00

  • Lack of potentiation by cetirizine of alcohol-induced psychomotor disturbances.

    abstract::The possible interaction between cetirizine 2 HCl and alcohol was studied in a double-blind, cross-over trial in 36 healthy volunteers. The performance of each volunteer was tested with a battery of five objective psychometric tests, and their subjective feelings were evaluated by visual analogue scales, and by extens...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00615227

    authors: Doms M,Vanhulle G,Baelde Y,Coulie P,Dupont P,Rihoux JP

    更新日期:1988-01-01 00:00:00

  • Influence of bariatric surgery on the use of medication.

    abstract:PURPOSE:Bariatric surgery can influence the prevalence and incidence of comorbidities, as well as the pharmacokinetics of drugs. This might lead to changes in the use of drugs. This study aimed to assess the influence of bariatric surgery on the use of medication in patients before and after surgery, focusing on type, ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-015-1971-3

    authors: Yska JP,van der Meer DH,Dreijer AR,Eilander W,Apers JA,Emous M,Totté ER,Wilffert B,van Roon EN

    更新日期:2016-02-01 00:00:00

  • Effect of Liv.52, a herbal preparation, on absorption and metabolism of ethanol in humans.

    abstract::In 8 social drinkers, the effect of a single dose of Liv.52 or placebo on ethanol absorption has been studied after ingestion of 30 ml whisky in 5 min. The t1/2 absorption with Liv.52 was 3.62 min, significantly less than after placebo, 6.29 min. The peak concentration after Liv.52 (49.9 mg.100 ml-1) was significantly...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00280076

    authors: Chauhan BL,Kulkarni RD

    更新日期:1991-01-01 00:00:00

  • Altered pharmacokinetics of lignocaine after epidural injection in type II diabetics.

    abstract::The pharmacokinetics of lignocaine has been compared after epidural anaesthesia in diabetics and non-diabetic patients. Epidural lignocaine 8 mg.kg-1 was given to 8 well controlled Type II diabetic and 8 non-diabetic patients and the plasma drug concentration in serial blood samples were measured by HPLC. The plasma l...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF02333021

    authors: Peeyush M,Ravishankar M,Adithan C,Shashindran CH

    更新日期:1992-01-01 00:00:00

  • Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery.

    abstract::The binding equilibria of warfarin and phenprocoumon with defatted human serum albumin were studied by equilibrium dialysis in 33 mM sodium phosphate buffer, pH 7.4, 37 degrees C. The binding isotherms for both ligands were consistent with binding to two similar and independent sites in the albumin molecule. The bindi...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00315474

    authors: Vorum H,Jørgensen HR,Brodersen R

    更新日期:1993-01-01 00:00:00

  • Clinical and therapeutic use of probucol.

    abstract::Previous studies showed that probucol significantly lowered both LDL cholesterol and HDL cholesterol. In addition, there is evidence that as an essential antioxidant probucol causes variations in cellular interactions and cardiovascular functions in patients. Therefore, 14 hypercholesterolemic men were investigated be...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:

    authors: Berg A,Baumstark MW,Frey I,Halle M,Keul J

    更新日期:1991-01-01 00:00:00

  • Modelling circadian variation in the pharmacokinetics of non-steroidal anti-inflammatory drugs.

    abstract::A one-compartment model with first-order absorption has provided good fits to five sets of indomethacin data and four sets of ketoprofen data taken at different times of day. There was substantial variation in the model parameters with time of administration and most of the features of this variation applied equally t...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00265955

    authors: Aronson JK,Chappell MJ,Godfrey KR,Yew MK

    更新日期:1993-01-01 00:00:00

  • Preliminary observations on the biliary elimination of mebendazole and its metabolites in patients with echinococcosis.

    abstract::The biliary excretion of mebendazole has been investigated in two patients to whom it was given for the treatment of echinococcosis, although it was found to be only partly effective. Oral mebendazole was extensively metabolized and the conjugated parent substance and its metabolites were excreted in the bile. One pat...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00544020

    authors: Witassek F,Allan RJ,Watson TR,Woodtli W,Ammann R,Bircher J

    更新日期:1983-01-01 00:00:00

  • Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tablets.

    abstract::In a cross-over pharmacokinetic study in 8 healthy volunteers a retard formulation containing pindolol 30 mg was compared with the normal 15 mg. pindolol tablet. The pindolol 30 mg retard tablet led to the same maximum plasma level as a single dose of the normal pindolol tablet. A plasma concentration higher than half...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00542037

    authors: Aellig WH,Nüesch E,Pacha W

    更新日期:1982-01-01 00:00:00

  • Enprofylline pharmacokinetics in children with asthma.

    abstract::The pharmacokinetics of intravenous enprofylline has been studied in 8 children with asthma. The mean plasma half-life of enprofylline (1.0 h) was considerably shorter than that previously reported in adults. The half-life determined from log urine excretion rate data was identical to the plasma half-life, so urine ex...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00637683

    authors: Hultqvist C,Borgå O

    更新日期:1987-01-01 00:00:00

  • Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence.

    abstract:PURPOSE:Persistence to statins is low, in part due to lack of perception of cardiovascular (CV) risk. High values of low-density lipoprotein cholesterol (LDL-C) might increase the motivation for patients to be persistent. We investigated whether the baseline LDL-C value influences the discontinuation of statin treatmen...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-015-1996-7

    authors: Citarella A,Linder M,Kieler H,Berglind IA,Sundström A,Wettermark B,Andersen M

    更新日期:2016-03-01 00:00:00

  • Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil.

    abstract::To evaluate the influence of the stomach and the cholinergic system on gallbladder contraction induced by physiological stimuli, the reduction in gallbladder volume in 7 healthy volunteers has been studied by real-time ultrasonography after the oral and intraduodenal administration of olive oil, preceded by pretreatme...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00315412

    authors: Marzio L,Di Felice F,Celiberti V,Pieramico O,Grossi L,DiGioacchino M,Imbimbo BP,Cuccurullo F

    更新日期:1990-01-01 00:00:00

  • Single- and multiple-dose pharmacokinetics of terodiline in geriatric patients.

    abstract::As a target group, geriataric patients were selected for pharmacokinetic studies with terodiline (Mictrol), an anticholinergic and calcium antagonist drug effective in the treatment of urinary incontinence. The single-dose kinetics in the geriatric patients (mean age 82 years) differed significantly from that previous...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00540958

    authors: Hallén B,Magnusson A,Bogentoft S,Ekelund P

    更新日期:1988-01-01 00:00:00

  • Clinical experience of encainide (MJ 9067): a new anti-arrhythmic drug.

    abstract::Encainide is a new anti-arrhythmic drug, which is highly effective against ventricular extrasystoles, both single and coupled, in the dose range of 80--140 mg i.v. Ventricular extrasystoles were abolished in 31 out of 33 cases treated. The drug is also relatively effective against supraventricular extrasystoles, but h...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF00605629

    authors: Kesteloot H,Stroobandt R

    更新日期:1979-11-01 00:00:00

  • Frequency of S-mephenytoin hydroxylation deficiency in 373 Spanish subjects compared to other Caucasian populations.

    abstract::We have investigated the prevalence of poor metabolisers (PM) of S-mephenytoin in 373 unrelated, healthy Spanish Caucasian subjects, based on the enantiomeric S/R mephenytoin ratio in urine collected 0-8 h and 24-32 h after intake of the racemic drug. Five of the subjects were PM (1.34%, 95% confidence interval 0.18-2...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF02440867

    authors: Reviriego J,Bertilsson L,Carrillo JA,Llerena A,Valdivielso MJ,Benítez J

    更新日期:1993-01-01 00:00:00

  • Pharmacokinetics and beta-blocking effects of transdermal timolol.

    abstract::The pharmacokinetic profiles of transdermal timolol 6 and 24 mg (as 5 and 20% w/v patches) was studied in four healthy young volunteers. To assess its bioavailability, the pharmacokinetics of an IV infusion of timolol maleate 5 mg was also determined in the same subjects. When the 20% (w/v) timolol patch was applied, ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00315551

    authors: Kubota K,Yamada T,Kikuchi K,Koyama E,Ishizaki T

    更新日期:1993-01-01 00:00:00

  • The effects of omeprazole-induced hypochlorhydria on absorption of theophylline from a sustained-release formulation.

    abstract::The present study was designed to investigate the effects of raised intragastric pH on the absorption of theophylline from a sustained-release formulation. Six healthy male volunteers participated in the cross-over randomised study and on one of two occasions were pretreated with 240 mg omeprazole, administered in thr...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF01740660

    authors: Sommers DK,van Wyk M,Snyman JR,Moncrieff J

    更新日期:1992-01-01 00:00:00